Norfloxacin disposition after sequentially increasing oral doses.
Single doses of norfloxacin (200, 400, 800, 1,200, and 1,600 mg) or placebo were administered orally at weekly intervals to 14 healthy male volunteers in a double-blind study. Norfloxacin was measured in serum and urine by high-pressure liquid chromatography with UV detection. The concentrations of this drug in serum peaked 1 to 2 h after each dose; the mean peak values for increasing doses were 0.75, 1.58, 2.41, 3.15, and 3.87 micrograms/ml. Mean area under the serum concentration-time curves for the first 12 h after each dose were 3.56, 6.26, 11.4, 16.1, and 19.7 micrograms . h/ml, respectively. The elimination half-life of norfloxacin was about 7 h and was similar for all doses. The concentrations of the drug in urine also peaked 1 to 2 h after dosage; mean peak values for increasing doses were 200, 478, 697, 992, and 1,045 micrograms/ml. Renal clearances approximated 285 ml/min. About 30% of each dose was excreted into urine as unmetabolized norfloxacin. Crystals of the drug were occasionally observed during microscopic examination of freshly voided urine collected after the 1,200- and 1,600-mg doses. Crystalluria was not encountered at lower doses.
D000284:Administration, Oral; D000328:Adult; D000890:Anti-Infective Agents / Q000378:metabolism*; D003460:Crystallization; D006207:Half-Life; D006801:Humans; D008297:Male; D009268:Nalidixic Acid / Q000031:analogs & derivatives* / Q000378:metabolism; D009643:Norfloxacin; D012995:Solubility
D000890:Anti-Infective Agents; D009268:Nalidixic Acid; D009643:Norfloxacin